Skip to main content
. 2022 Nov 15;12(11):5095–5104.

Table 5.

Prognostic factors associated with LRRC patients received surgery

Variables Univariable Multivariable


Hazards ratio 95% CI P value Hazards ratio 95% CI P value
Differentiation: poor vs. well/moderate 1.16 0.65-2.07 0.61
Lymphovascular invasion: yes vs. no 4.15 2.22-7.79 < 0.001 3.55 1.72-7.35 < 0.001
Surgical margin: positive vs. negative 2.00 0.56-2.80 < 0.001 1.97 0.68-3.57 < 0.001
Re-neoadjuvant chemotherapy: yes vs. no 0.60 0.36-0.99 0.04 0.51 0.16-1.68 0.27
Re-neoadjuvant radiotherapy: yes vs. no 0.33 0.04-1.16 0.03 0.41 0.21-2.41 0.04
Adjuvant chemotherapy: Yes vs. no 0.89 0.49-1.63 0.71
Adjuvant radiotherapy: Yes vs. no 0.87 0.34-2.22 0.77